Yuemin Nan

3.2k total citations · 1 hit paper
117 papers, 1.6k citations indexed

About

Yuemin Nan is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Yuemin Nan has authored 117 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Epidemiology, 66 papers in Hepatology and 19 papers in Molecular Biology. Recurrent topics in Yuemin Nan's work include Liver Disease Diagnosis and Treatment (82 papers), Hepatitis B Virus Studies (37 papers) and Hepatitis C virus research (29 papers). Yuemin Nan is often cited by papers focused on Liver Disease Diagnosis and Treatment (82 papers), Hepatitis B Virus Studies (37 papers) and Hepatitis C virus research (29 papers). Yuemin Nan collaborates with scholars based in China, Hong Kong and United States. Yuemin Nan's co-authors include Suxian Zhao, Rongqi Wang, Na Fu, Yuguo Zhang, Lingbo Kong, Jun Yu, Jinghua Du, Wenjuan Wu, Jingmin Zhao and Weiguang Ren and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Yuemin Nan

106 papers receiving 1.6k citations

Hit Papers

Guidelines for the Prevention and Treatment of Chronic He... 2023 2026 2024 2025 2023 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)
    2023 97 citations Hong You, Xiaoyuan Xu et al. Journal of Clinical and Translational Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuemin Nan China 23 997 670 508 255 180 117 1.6k
Bedair Dewidar Germany 8 764 0.8× 689 1.0× 420 0.8× 120 0.5× 244 1.4× 16 1.4k
Suxian Zhao China 19 630 0.6× 374 0.6× 429 0.8× 255 1.0× 168 0.9× 58 1.2k
Xiaodong Ge United States 17 631 0.6× 432 0.6× 425 0.8× 150 0.6× 215 1.2× 40 1.5k
Takemi Akahane Japan 24 766 0.8× 529 0.8× 565 1.1× 232 0.9× 280 1.6× 108 1.8k
Christophe Van Steenkiste Belgium 23 844 0.8× 720 1.1× 436 0.9× 159 0.6× 344 1.9× 68 1.6k
Xavier Verhelst Belgium 25 898 0.9× 692 1.0× 439 0.9× 144 0.6× 425 2.4× 104 1.8k
Ariel E. Feldstein United States 15 958 1.0× 544 0.8× 680 1.3× 106 0.4× 237 1.3× 23 1.7k
Raquel Urtasun Spain 23 511 0.5× 445 0.7× 710 1.4× 184 0.7× 212 1.2× 38 1.5k
Robert Schierwagen Germany 29 1.4k 1.4× 1.2k 1.8× 466 0.9× 185 0.7× 491 2.7× 91 2.3k
Alişan Kahraman Germany 19 900 0.9× 545 0.8× 294 0.6× 77 0.3× 300 1.7× 62 1.4k

Countries citing papers authored by Yuemin Nan

Since Specialization
Citations

This map shows the geographic impact of Yuemin Nan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuemin Nan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuemin Nan more than expected).

Fields of papers citing papers by Yuemin Nan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuemin Nan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuemin Nan. The network helps show where Yuemin Nan may publish in the future.

Co-authorship network of co-authors of Yuemin Nan

This figure shows the co-authorship network connecting the top 25 collaborators of Yuemin Nan. A scholar is included among the top collaborators of Yuemin Nan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuemin Nan. Yuemin Nan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ding, Yanbing, et al.. (2025). Research progress on the regulatory role of different cell death pathways in metabolic-dysfunction-associated steatotic liver disease. Clinics and Research in Hepatology and Gastroenterology. 49(6). 102578–102578. 1 indexed citations
2.
Wu, Tao, L. Li, Yayuan Mei, et al.. (2025). Increased BMD in SLD Patients Without Advanced Hepatic Fibrosis: Evidence From the NHANES 2017–2020 Database. Canadian Journal of Gastroenterology and Hepatology. 2025(1). 6969761–6969761.
3.
Zhao, Suxian, Jie Li, Lingdi Liu, et al.. (2025). Consensus on the Management of Liver Injury Associated with Targeted Drugs and Immune Checkpoint Inhibitors for Hepatocellular Carcinoma (Version 2024). Journal of Clinical and Translational Hepatology. 0(0). 0–0.
4.
Fan, Jian‐Gao, Xiaoyuan Xu, Yuemin Nan, et al.. (2024). Guideline for the Prevention and Treatment of Metabolic Dysfunction-associated Fatty Liver Disease (Version 2024). Journal of Clinical and Translational Hepatology. 0(0). 0–0. 22 indexed citations
5.
6.
You, Hong, Weijia Duan, Shuxiang Li, et al.. (2023). Guidelines on the Diagnosis and Management of Primary Biliary Cholangitis (2021). Journal of Clinical and Translational Hepatology. 0(0). 0–0. 13 indexed citations
7.
Li, Minghui, Xiaojuan Ou, Sujun Zheng, et al.. (2023). Lower end of treatment HBsAg and HBcrAg were associated with HBsAg loss after nucleos(t)ide analog cessation. BMC Gastroenterology. 23(1). 224–224. 4 indexed citations
8.
9.
Hou, Mengmeng, et al.. (2023). Mitofusin-2 gene polymorphisms and metabolic dysfunction associated fatty liver disease: a case-control study in a Chinese population. Journal of International Medical Research. 51(7). 3639248881–3639248881. 2 indexed citations
10.
Dong, Shiming, et al.. (2023). LINC00886 Facilitates Hepatocellular Carcinoma Tumorigenesis by Sequestering microRNA-409-3p and microRNA-214-5p. Journal of Hepatocellular Carcinoma. Volume 10. 863–881. 5 indexed citations
11.
Dong, Shiming, et al.. (2023). Heme oxygenase‐1 prevents non‐alcoholic steatohepatitis through modulating mitochondrial quality control. Acta Physiologica. 237(3). e13918–e13918. 9 indexed citations
12.
Zhao, Suxian, et al.. (2022). Identification of potential plasma markers for hepatitis B virus‐related chronic hepatitis and liver fibrosis/cirrhosis. Journal of Medical Virology. 94(8). 3900–3910. 5 indexed citations
13.
14.
Nan, Yuemin, et al.. (2022). Adverse Effect of Nonalcoholic Fatty Liver Disease on the Therapeutic Response in Patients with Chronic Hepatitis B. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 6 indexed citations
15.
16.
Zhao, Wen, et al.. (2021). Plasma Yap1 Predicts Esophageal Varices and The Risk of Variceal Bleeding in Liver Cirrhosis. Biomarkers in Medicine. 15(15). 1411–1422. 2 indexed citations
17.
Zhao, Suxian, et al.. (2020). Yiqi Huoxue Recipe Improves Liver Regeneration in Rats after Partial Hepatectomy via JNK Pathway. Evidence-based Complementary and Alternative Medicine. 2020(1). 9085801–9085801. 7 indexed citations
18.
Du, Jinghua, Weiguang Ren, Qingshan Zhang, et al.. (2020). Heme Oxygenase‐1 Suppresses Wnt Signaling Pathway in Nonalcoholic Steatohepatitis‐Related Liver Fibrosis. BioMed Research International. 2020(1). 4910601–4910601. 9 indexed citations
19.
Kong, Lingbo, Lu Yu, Siyu Zhang, Yuemin Nan, & Liang Qiao. (2017). Role of nutrition, gene polymorphism, and gut microbiota in non-alcoholic fatty liver disease.. PubMed. 24(131). 95–106. 16 indexed citations
20.
Zhao, Suxian, Na Fu, Shanshan Su, et al.. (2016). Involvement of the Interleukin-23/Interleukin-17 Axis in Chronic Hepatitis C Virus Infection and Its Treatment Responses. International Journal of Molecular Sciences. 17(7). 1070–1070. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bedair Dewidar Breakdown of academic impact, for papers by Suxian Zhao Breakdown of academic impact, for papers by Xiaodong Ge Breakdown of academic impact, for papers by Takemi Akahane Breakdown of academic impact, for papers by Christophe Van Steenkiste Breakdown of academic impact, for papers by Xavier Verhelst Breakdown of academic impact, for papers by Ariel E. Feldstein Breakdown of academic impact, for papers by Raquel Urtasun Breakdown of academic impact, for papers by Robert Schierwagen Breakdown of academic impact, for papers by Alişan Kahraman
Rankless by CCL
2026